FINANCIAL CALENDARS

Year 2025 

• March 12, 2025

Board of Directors to approve the draft financial statements and consolidated financial statements as of December 31, 2024;

• March 12, 2025

Conference Call Analysts-Investors FY 2024;

• April 28, 2025 (single call)

Shareholders' Meeting to approve the annual financial statements as of December 31, 2024 and presentation of the consolidated financial statements as of December 31, 2024;

• May 14, 2025

Board of Directors to approve additional consolidated financial information as of March 31, 2025;

• May 15, 2025

Analyst-Investor Conference Call additional consolidated financial information as of March 31, 2025;

• September 11, 2025

Board of Directors to approve the consolidated interim financial report as of June 30, 2025;

• September 12, 2025

Conference Call Analysts-Investors consolidated half-yearly financial report as of June 30, 2025;

• November 13, 2025

Board of Directors to approve additional consolidated financial information as of September 30, 2025;

• November 14, 2025

Conference Call Analysts-Investors additional consolidated financial information as of September 30, 2025.

Year 2024

02/02/2024

Board of Directors to approve preliminary annual results as of 31st December 2023

14/03/2024

Board of Directors to approve the draft annual financial statements as of 31st December 2023 and the consolidated financial statements as of 31st December 2023

15/03/2024

Analysts-Investors Conference Call FY 2023

22/04/2024 (1st Call)

Shareholders' Meeting to approve the financial statements as of 31st December 2023 and present the consolidated financial statements as of 31st December 2023

23/04/2024 (2nd Call)

Shareholders' Meeting to approve the financial statements as of 31st December 2023 and present the consolidated financial statements as of 31st December 2023

14/05/2024

Board of Directors to approve the additional consolidated financial information as of 31st March 2024

15/05/2024

Analysts-Investors Conference Call additional consolidated financial information as of 31st March 2024

12/09/2024

Board of Directors to approve the half-yearly consolidated financial report as of 30th June 2024

13/09/2024

Analysts-Investors Conference Call half-yearly consolidated financial report as of 30th June 2024

12/11/2024

Board of Directors to approve the additional consolidated financial information as of 30th September 2024

13/11/2024

Analysts-Investors Conference Call additional consolidated financial information as of 30th September 2024

Year 2023

23/03/2023

Board of Directors to approve the draft annual financial statements as of 31st December 2022

24/03/2023

Analysts-Investors Conference Call FY 2022

27/04/2023 (1st Call)

Ordinary Shareholders’ Meeting to approve the financial statements as of 31st December 2022

28/04/2023 (2nd Call)

Ordinary General Meeting to approve the financial statements as of 31st December 2022

13/09/2023

Board of Directors to approve the half-yearly financial report as of 30th June 2023

14/09/2023

Analysts-Investors Conference Call 1H 2023

14/11/2023

Board of Directors to approve the interim management report as of 30th September 2023

15/11/2023

Analysts-Investors Conference Call Q3 2023

Year 2022 

17/03/2022

Board of Directors to approve the draft financial statements as of 31 December 2021

18/03/2022

Analysts-Investors Conference Call FY 2021

14/04/2022 (1st Call)

Ordinary Shareholders' Meeting to approve the financial statements for the year ended 31st December 2021

19/04/2022 (2nd Call)

Ordinary Shareholders' Meeting to approve the financial statements as of 31st December 2021

21/09/2022

Board of Directors to approve the half-yearly financial report as of 30th June 2022

22/09/2022

Analysts-Investors Conference Call 1H 2022

Year 2021